| ISIN | CH0435830622 |
|---|---|
| Valor Number | 43583062 |
| Bloomberg Global ID | ZKBASCA SW |
| Fund Name | ZugerKB Fonds - Aktien ESG Schweiz (CHF) A |
| Fund Provider |
Zuger Kantonalbank AG, Zug
Baarerstrasse 37 6301 Zug Phone: +41 41 709 11 11 |
| Fund Provider | Zuger Kantonalbank AG, Zug |
| Representative in Switzerland | |
| Distributor(s) | Zuger Kantonalbank, Zug |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | Das Anlageziel des Teilvermögens ZugerKB Fonds - Aktien Schweiz (CHF) besteht in einem langfristig möglichst hohen Anlageertrag in der Rechnungseinheit CHF. |
| Peculiarities |
| Current Price * | 145.62 CHF | 30.10.2025 |
|---|---|---|
| Previous Price * | 145.32 CHF | 29.10.2025 |
| 52 Week High * | 155.14 CHF | 03.03.2025 |
| 52 Week Low * | 129.22 CHF | 09.04.2025 |
| NAV * | 145.62 CHF | 30.10.2025 |
| Issue Price * | 145.62 CHF | 30.10.2025 |
| Redemption Price * | 145.62 CHF | 30.10.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 236,426,452 | |
| Unit/Share Assets *** | 131,603,962 | |
| Trading Information SIX | ||
| YTD Performance | +4.32% |
31.12.2024 - 30.10.2025
31.12.2024 30.10.2025 |
|---|---|---|
| 1 month | +1.48% |
30.09.2025 - 30.10.2025
30.09.2025 30.10.2025 |
| 3 months | -0.22% |
30.07.2025 - 30.10.2025
30.07.2025 30.10.2025 |
| 6 months | +0.24% |
30.04.2025 - 30.10.2025
30.04.2025 30.10.2025 |
| 1 year | +2.01% |
30.10.2024 - 30.10.2025
30.10.2024 30.10.2025 |
| 2 years | +23.21% |
30.10.2023 - 30.10.2025
30.10.2023 30.10.2025 |
| 3 years | +25.97% |
31.10.2022 - 30.10.2025
31.10.2022 30.10.2025 |
| 5 years | +42.32% |
30.10.2020 - 30.10.2025
30.10.2020 30.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 8.83% | |
|---|---|---|
| Nestle SA | 8.25% | |
| Lonza Group Ltd | 6.50% | |
| UBS Group AG Registered Shares | 6.46% | |
| Novartis AG Registered Shares | 6.39% | |
| Sika AG | 5.47% | |
| Alcon Inc | 5.34% | |
| ABB Ltd | 5.24% | |
| Zurich Insurance Group AG | 4.20% | |
| Swiss Re AG | 4.04% | |
| Last data update | 30.06.2025 | |
| TER | 1.30% |
|---|---|
| TER date | 31.05.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.60% |
| Ongoing Charges *** | 1.32% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |